Zura Bio Limited, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • September 3rd, 2024 • Zura Bio LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 3rd, 2024 Company Industry JurisdictionIndenture, dated as of [·], 20__, among Zura Bio Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), and[Trustee], as trustee (the “Trustee”):
COMPASS THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20_____ Debt SecuritiesIndenture • August 30th, 2024 • Compass Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 30th, 2024 Company Industry JurisdictionTHIS INDENTURE, dated as of [•], 20___, between COMPASS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
BRAINSTORM CELL THERAPEUTICS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • August 28th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 28th, 2024 Company Industry JurisdictionINDENTURE, dated as of [●], 202[●] , among BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):